2013 Press releases


Displaying 1 - 10 of 29



18 November 2013
Third Quarter Results 2013

Aqualis ASA (OSE: AQUA), announces its results for the third quarter 2013, including significant post-period events.


8 November 2013
Aqualis ASA enters the offshore market through the acquisition of Aqualis Offshore

Aqualis ASA (OSE: AQUA) has today successfully completed the acquisition of 100% of the shares in Aqualis Offshore Ltd., a specialized offshore marine and engineering consultancy group, for NOK 70 million.


4 November 2013
Final result of the Rights Issue

Aqualis ASA (OSE: AQUA), reference is made to the stock exchange notice published on 30 October 2013 regarding the oversubscribed Rights Issue and Employee Offering. The Board of Directors of the Company has today approved the final allocation of the shares offered in the Rights Issue, which was approximately 75% oversubscribed, and the Employee Offering.


30 October 2013
Rights Issue significantly oversubscribed

Aqualis ASA (OSE: AQUA), reference is made to the stock exchange notice published on 15 October 2013 regarding the commencement of the subscription period in the NOK 54 million Rights Issue. The subscription period for the Rights Issue and the trading period for the subscription rights expired yesterday, 29 October 2013, at 16:30 hours (CET).


18 October 2013
Oslo Børs Approved Prospectus and commencement of Subscription Period

Aqualis ASA (OSE: AQUA), reference is made to the stock exchange notices published by Aqualis ASA (the “Company”) on 8 October 2013 and 27 September 2013 regarding minutes from the Extraordinary General Meeting and the signed final agreement to acquire Aqualis Offshore.


10 October 2013
Appoints Chief Business Officer responsible for Healthcare activities

Aqualis ASA (formerly Clavis Pharma ASA) is pleased to announce the appointment of Ole Henrik Eriksen as Chief Business Officer, Healthcare. Mr Eriksen will be responsible for developing the Company’s pharmaceutical assets, including the current portfolio of patents and licensing agreements, as well as investigating new investment opportunities within the healthcare sector.


9 October 2013
Company name changed to Aqualis ASA

Reference is made to the stock exchange notice of the extraordinary general meeting of Clavis Pharma ASA held on 8 October 2013, at which the general meeting resolved to change the company's name to Aqualis ASA. The new company name is now registered in the Norwegian Register of Business Enterprises.


9 October 2013
Ex right to participate in Rights Issue today

Clavis Pharma ASA (OSE: CLAVIS), reference is made to the announcement yesterday, 8 October 2013, regarding the Minutes from the Extraordinary General Meeting and the resolved acquisition of 100% of the shares in Aqualis Offshore Ltd and the new share issue of NOK 54 million, with preemptive rights for shareholders of the Company (the “Rights Issue”).


8 October 2013
Minutes from Extraordinary General Meeting 8 October 2013

Clavis Pharma ASA (OSE: CLAVIS), the Extraordinary General Meeting of Clavis Pharma ASA was held on 8 October 2013. Please find the minutes of the Extraordinary General Meeting attached.


4 October 2013
Information from Election Committee

Clavis Pharma ASA (OSE: CLAVIS), reference is made to the announcement on 17 September 2013 regarding Clavis Pharma’s Extraordinary General Meeting to be held on 8 October, and agenda item 7: Election of Board. Please find attached additional information from the Election Committee in regards to this agenda item.